share_log

HCA Healthcare | 8-K: Current report

HCA Healthcare | 8-K: Current report

HCA醫療 | 8-K:重大事件
美股SEC公告 ·  2024/08/09 05:00

Moomoo AI 已提取核心訊息

HCA Healthcare and its subsidiary HCA Inc. have entered into an underwriting agreement on August 7, 2024, for the issuance of $3 billion in senior notes across three tranches. The offering includes $750 million of 5.450% Senior Notes due 2031, $1.25 billion of 5.450% Senior Notes due 2034, and $1 billion of 5.950% Senior Notes due 2054.The 2031 Notes will be issued as additional notes under the existing indenture governing the $1 billion 5.450% Senior Notes issued in February 2024. These new notes will have identical terms with the existing notes, except for their issue date and public offering price, and will be fully fungible with the existing 2031 Notes.The notes will be guaranteed on a senior unsecured basis by HCA Healthcare. Citigroup Global Markets, BofA Securities, J.P. Morgan Securities, and Wells Fargo Securities are serving as representatives of the underwriters for this offering.
HCA Healthcare and its subsidiary HCA Inc. have entered into an underwriting agreement on August 7, 2024, for the issuance of $3 billion in senior notes across three tranches. The offering includes $750 million of 5.450% Senior Notes due 2031, $1.25 billion of 5.450% Senior Notes due 2034, and $1 billion of 5.950% Senior Notes due 2054.The 2031 Notes will be issued as additional notes under the existing indenture governing the $1 billion 5.450% Senior Notes issued in February 2024. These new notes will have identical terms with the existing notes, except for their issue date and public offering price, and will be fully fungible with the existing 2031 Notes.The notes will be guaranteed on a senior unsecured basis by HCA Healthcare. Citigroup Global Markets, BofA Securities, J.P. Morgan Securities, and Wells Fargo Securities are serving as representatives of the underwriters for this offering.
HCA醫療及其子公司HCA Inc.於2024年8月7日簽署了一項承銷協議,發行30億的高級票據,分爲三部分。此次發行包括75000萬的5.450% 2031年到期的高級票據、12.5億的5.450% 2034年到期的高級票據,以及10億的5.950% 2054年到期的高級票據。2031年票據將作爲額外票據在2024年2月發行的10億5.450%高級票據的現有契約下發行。這些新票據將與現有票據的條款完全相同,唯一的不同在於發行日期和公開發行價格,並且將與現有的2031年票據完全可互換。這些票據將由HCA醫療提供高級無抵押保障。花旗集團全球市場、美國銀行證券、高盛證券和富國銀行證券將作爲此次發行的承銷商的代表。
HCA醫療及其子公司HCA Inc.於2024年8月7日簽署了一項承銷協議,發行30億的高級票據,分爲三部分。此次發行包括75000萬的5.450% 2031年到期的高級票據、12.5億的5.450% 2034年到期的高級票據,以及10億的5.950% 2054年到期的高級票據。2031年票據將作爲額外票據在2024年2月發行的10億5.450%高級票據的現有契約下發行。這些新票據將與現有票據的條款完全相同,唯一的不同在於發行日期和公開發行價格,並且將與現有的2031年票據完全可互換。這些票據將由HCA醫療提供高級無抵押保障。花旗集團全球市場、美國銀行證券、高盛證券和富國銀行證券將作爲此次發行的承銷商的代表。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息